The drugmaker will pay $10 million in the case, plus additional contributions worth $10.4 million, to avoid going to trial in two Ohio counties for its role in the opioids crisis. Health New York TimesBy Unknown Author from NYT Health https://ift.tt/2nrLBm9
October 1, 2019 at 03:26PM
No comments:
Post a Comment